Alzheimer’s disease (AD) and related dementias present significant challenges in therapeutic development, particularly within ...

In recent years, the field of oncology has increasingly acknowledged cancer as a metabolic disorder with significant ...

Nectin-4 and Trop-2 expression as potential therapeutic target in collecting duct carcinoma: Preliminary results from the CICERONE trial (NCT05372302). This is an ASCO Meeting Abstract from the 2025 ...

Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna Akalin, PhD, head of the bioinformatics and omics data science technology ...

A recent study developed a highly accurate risk prediction framework for preterm birth (PTB) that could broaden the potential of AI-driven multi-omics applications in precision obstetrics and ...

Colorectal cancer is among the most prevalent and lethal malignancies worldwide, with liver metastases occurring in nearly one-third of patients and accounting for a major share of cancer-related ...

Dietrich A. Stephan, Ph.D., Executive Chair, Enhanced Genomics, said: “I am thrilled to welcome Katerina as the newest member ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial ...

A groundbreaking review in Biological Diversity proposes a proactive, AI - integrated approach to stop biological invasions ...